tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Quest Diagnostics: FDA grants Breakthrough Device Designation for Haystack MRD
PremiumThe FlyQuest Diagnostics: FDA grants Breakthrough Device Designation for Haystack MRD
23d ago
Quest Diagnostics downgraded to Neutral from Outperform at Baird
Premium
The Fly
Quest Diagnostics downgraded to Neutral from Outperform at Baird
24d ago
Quest Diagnostics price target lowered to $190 from $200 at Piper Sandler
Premium
The Fly
Quest Diagnostics price target lowered to $190 from $200 at Piper Sandler
2M ago
Quest Diagnostics price target raised to $192 from $190 at Truist
PremiumThe FlyQuest Diagnostics price target raised to $192 from $190 at Truist
2M ago
Quest Diagnostics price target raised to $178 from $160 at Deutsche Bank
Premium
The Fly
Quest Diagnostics price target raised to $178 from $160 at Deutsche Bank
2M ago
Quest Diagnostics: Strong Financial Outlook and Strategic Positioning Justify Buy Rating
Premium
Ratings
Quest Diagnostics: Strong Financial Outlook and Strategic Positioning Justify Buy Rating
2M ago
Quest Diagnostics’ Strong Q2 Performance and Upgraded Guidance Reinforce Buy Rating
PremiumRatingsQuest Diagnostics’ Strong Q2 Performance and Upgraded Guidance Reinforce Buy Rating
2M ago
Quest Diagnostics reports Q2 adjusted EPS $2.62, consensus $2.58
Premium
The Fly
Quest Diagnostics reports Q2 adjusted EPS $2.62, consensus $2.58
2M ago
Quest Diagnostics raises FY25 adjusted EPS view to $9.63-$9.83 from $9.55-$9.80
Premium
The Fly
Quest Diagnostics raises FY25 adjusted EPS view to $9.63-$9.83 from $9.55-$9.80
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100